Godavari Drugs Limited (BOM:530317)

India · Delayed Price · Currency is INR

115.00

-3.40 (-2.87%)

At close: Jul 27, 2026

Godavari Drugs Financials Overview

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	1,066	1,066	1,141	1,572	1,596	1,613
Revenue Growth	-6.57%	-6.57%	-27.42%	-1.50%	-1.01%	31.31%
Gross Profit	291.16	291.16	312.39	350.35	301.26	284.42
Operating Income	86.88	86.88	104.42	119.78	99.15	99.94
Net Income	40.89	40.89	43.8	55.49	37.86	52.45
Earnings Per Share	5.36	5.36	5.82	7.37	5.03	6.97
EPS Growth	-7.90%	-7.90%	-21.03%	46.52%	-27.83%	27.19%

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Investments	145.09	145.09	23.73	26.23	30.85	22.76
Total Debt	763.58	763.58	643.46	577.7	573.22	230.73
Net Cash (Debt)	-618.49	-618.49	-619.73	-551.47	-542.38	-207.96
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-81.07	-81.07	-82.35	-73.25	-72.06	-27.63

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Cash Flow	7.34	7.34	111.96	184.14	132.17	112.3
Capital Expenditures	-267.23	-267.23	-199.98	-132.01	-93.36	-52.45
Free Cash Flow	-259.9	-259.9	-88.02	52.12	38.81	59.85
Free Cash Flow Growth	-	-	-	34.30%	-35.15%	-

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Gross Margin	27.31%	27.31%	27.38%	22.28%	18.87%	17.64%
Operating Margin	8.15%	8.15%	9.15%	7.62%	6.21%	6.20%
Pretax Margin	4.75%	4.75%	4.93%	4.40%	3.09%	4.35%
Profit Margin	3.84%	3.84%	3.84%	3.53%	2.37%	3.25%
FCF Margin	-24.38%	-24.38%	-7.71%	3.31%	2.43%	3.71%

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul '26 Jul 28, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
PE Ratio	20.52	15.84	15.04	12.61	15.07	9.39
P/FCF Ratio	-	-	-	13.43	14.70	8.23
PS Ratio	0.78	0.61	0.58	0.45	0.36	0.31